Icahn Genomics Institute

Immunologists Push for State Biomedical Research Funding in New York - AAI News Dr. Shruti Naik is one of the immunologists in New York state behind NY-CURES, advocating for state investment in biomedical research.

Wondering why you should ✍ our petition? c.org/nDnRNSsVcq

In @aai.org, founder @drshrutinaik.bsky.social reveals why the coalition was formed, why NY needs a state-backed research institute, and how scientists should organize for systemic support — here and nationwide.
news.aai.org/2025/11/20/n...

Sign the Petition Support a New York State Biomedical Institute for a Healthier, More Affordable Future

📢 SIGN & SHARE THE PETITION! 📢

New York needs an Empire Biomedical Research Institute to create new statewide funding opportunities for scientists & physician-scientists so that patients and their families get the life-saving and life-changing new therapeutics they're hoping for ✏️ c.org/TDMy2H9JTW

AI-powered design accelerates the development of mRNA therapeutics - Nature Chemical Biology mRNA has emerged as an important class of therapeutic molecules. Now, an artificial intelligence (AI)-driven framework, which can design mRNA sequences with enhanced stability and translational effici...

In @natchembio.nature.com, @yizhoudonglab.bsky.social highlights GEMORNA, an AI framework that directly generates mRNA & circRNA sequences by jointly modeling CDSs & UTRs, for coordinated optimization of expression and stability.

An elegant tool to help design mRNAs!
www.nature.com/articles/s41...

🧬 mRNA has emerged as a powerful new class of therapeutic molecules—extending far beyond vaccines to cancer immunotherapy, protein replacement, and gene editing.

🧩 But designing mRNAs with strong, lasting protein expression remains a major challenge.

Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level Nature Biomedical Engineering - This Review explores strategies for targeting and tracking RNA-LNP drugs, monitoring their in vivo behaviour, enhancing tissue-specific delivery, and using synthetic...

Our new review in @natbiomedeng.nature.com is out!
RNA-loaded lipid nanoparticles (LNPs) have huge potential—but their strong liver and immune cell uptake has mostly confined them to vaccines and liver therapies. We explore how to move beyond those limits.
free to read 🔗 rdcu.be/eLxGs

New York Cures – NY-CURESNew York Cures Website NY-CURES is working to advance bold, state-backed investment in biomedical research—on the scale of successful initiatives in California and Texas—to grow New York’s leadership in science, innovation, and health.

The BIGGEST impact you can have with 1 minute today ⏱️

Add your name to show NY is ready for a statewide biomedical institute.

CA’s CIRM & TX’s CPRIT proved it works—billions returned, jobs created, cures accelerated. Let’s do even better for New York.

✍️ www.nycures.org/

YouTube video by Concordia A Conversation with New York Governor Kathy Hochul | 2025 Concordia Annual Summit

“States like New York have an opportunity to position ourselves as real leaders in so many different areas.” @governor.ny.gov

Like her, we believe NY is ready for revitalization—by launching a state-wide biomedical institute that boosts jobs, the economy & cures. www.youtube.com/watch?v=WVtF...

Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours - Nature An understanding of the molecular mechanisms promoting the generation of immunoregulatory and tumour-promoting monocytes and macrophages is key to breaking the cycle of tumour myelopoiesis and develop...

🔬Our paper from the @miriammerad.bsky.social lab is now online! This is a story shaped over years of cross-disciplinary endeavor at @sinaiimmuno.bsky.social and labs across the world. 🧵:
www.nature.com/articles/s41...

Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours - Nature An understanding of the molecular mechanisms promoting the generation of immunoregulatory and tumour-promoting monocytes and macrophages is key to breaking the cycle of tumour myelopoiesis and develop...

📝NEW STUDY📝 Cancer's first punch when battling the immune system may be rewiring myeloid progenitors in bone marrow so they become suppressive tumor macrophages blunting T-cell attacks. Find out how in @nature.com from @samhegde.bsky.social & @miriammerad.bsky.social 🧐 www.nature.com/articles/s41...